Traders should monitor future Form 4 filings for actual insider buying or selling activity. The Power of Attorney simplifies future compliance but does not indicate imminent transactions.
Price Chart
Executive Summary
Douglas W. Pagán, Chief Financial Officer of Kailera Therapeutics, filed a Form 3 disclosing an option grant for 700,799 shares, with the first 25% vesting on December 29, 2026, and monthly vesting thereafter. The filing also includes a Power of Attorney authorizing others to file on his behalf for Section 16 and Rule 144 compliance.
Key Facts
- Douglas W. Pagán, CFO of KLRA, filed a Form 3 on April 16, 2026.
- Reported ownership of a stock option to purchase 700,799 shares, granted on April 16, 2026.
- Option vests 25% on December 29, 2026, and the remainder in 36 equal monthly installments, subject to continued service.
- Filing includes a Power of Attorney naming Scott Akamine, John Mei, and Corey Manchester as authorized agents for future Section 16 and Form 144 filings.
Financial Impact
Option grant for 700,799 shares disclosed; no immediate financial impact as options are not exercisable yet and no cash or revenue implications.
Risk Factors
- Potential for future dilution upon option exercise.
- No immediate liquidity event or financial impact from the grant.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-159679 |
| Document: 0001193125-26-159679-index-headers.html | 0001193125-26-159679 |
| Document: 0001193125-26-159679-index.html | 0001193125-26-159679 |
| Document: 0001193125-26-159679.txt | 0001193125-26-159679 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 22d ago | 3 | $14.91 $12.92 | ▼ −13.35% | ▼ −12.85% | $10.39 (−30.32%) |
Aug 12, 2026 7w ago | 8-K | $17.97 $17.47 | ▼ −2.78% | ▼ −0.82% | $10.39 (−42.18%) |
Jul 31, 2026 9w ago | Court Ruling | $16.94 $18.66 | ▲ +10.15% | ▲ +6.64% | $10.39 (−38.67%) |
Jul 24, 2026 10w ago | Court Ruling | $17.69 $17.05 | ▼ −3.62% | ▼ −3.99% | $10.39 (−41.27%) |
Jun 5, 2026 16w ago | Press Release | $19.70 $19.67 | ▼ −0.15% | ▼ −2.26% | $10.39 (−47.26%) |
May 26, 2026 18w ago | 8-K | $21.91 $22.38 | ▲ +2.15% | ▲ +1.68% | $10.39 (−52.58%) |
May 26, 2026 18w ago | Press Release | $21.91 $22.59 | ▲ +3.10% | ▲ +1.90% | $10.39 (−52.58%) |
May 13, 2026 20w ago | Press Release | $21.11 $19.62 | ▼ −7.06% | ▼ −5.90% | $10.39 (−50.78%) |
Apr 20, 2026 23w ago | 8-K | $25.22 $23.82 | ▼ −5.55% | ▼ −6.63% | $10.39 (−58.80%) |
Apr 20, 2026 23w ago | Insider Cluster | $24.61 $23.51 | ▼ −4.47% | ▼ −5.38% | $10.39 (−57.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access